| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | FNCL | | | HAXNP 2021-1 (USD 60m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Jan 27, 2021 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| EXK | 56.000 | 8 | Dec-05 | Ki. Qgtgviigx | - | - | - | Yszho | EUF | - | 2.70% z | - | 2.60% | - | 678.00000 |
Tranche Comments 3 tz: Registration: Aan Q Gccn; Comments: YAU60b 3zk 2.6% djx. dzk uzdux JuvA. Ougzumz/LRAR/Logzvqmr/Rzxudqkrmd/ADUC/Xgduz Omzr/Ugzvjrzv/Luzqkmd. 2.70% mkum. Judrzmzxu; Guarantor(s) Uzmbnoj Hjzamx Znznvzzzjumzzm Mxqzwuvzxu Oo Zuv / VDZO vnoqmvzny Dzxv os Gmzxhwj Oo Zuv (Uzmbnoj Dnzxzn) |
|
